Longshenrongfa Pharmaceutical Industry: Zhao Zhengcai resigns as Chief Financial Officer, Xiao Rong takes over

Longshenrongfa Pharmaceutical Industry announced on September 26th that the company's board of directors recently received a written resignation letter from Chief Financial Officer Zhao Zhengcai. Zhao Zhengcai applied to resign from his positions as Chief Financial Officer of the company and Chief Financial Officer of its subsidiary Gansu Pharmaceutical Group Co., Ltd. due to work adjustments. After resigning, he will hold a position at the company's controlling shareholder and will no longer serve in any administrative position within the company or its subsidiaries. The resignation will take effect from the date it is delivered to the company's board of directors. On the same day, the company held the 21st meeting of the fifth board of directors, which reviewed and approved the proposal on the appointment of the company's Chief Financial Officer. Following the nomination by the company's general manager and the review and approval by the board's nomination committee and audit committee, the board of directors agreed to appoint Xiao Rong as Chief Financial Officer, with a term starting from the date of approval by this board meeting until the end of the fifth board of directors' term